Notify me when Southpoint Capital Advisors LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| FENC | Fennec Pharmaceuticals Inc. | Common Shares, no par value | 8% | $21,135,329 | 2,744,741 | Southpoint Master Fund, LP | 31 Dec 2025 | ||
| IBTA | Ibotta, Inc. | Class A Common Stock, par value $0.00001 per share | 1.1% | $9,936,333 | -$40,337,667 | 276,701 | -80% | Southpoint Master Fund, LP | 30 Jun 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|